• 1. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 2. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 3. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 4. An Assessment of the Laminar Hypersonic Double-Cone Experiments in the LENS-XX Tunnel
  JaideepRay,PatrickBlonigan,EricT.Phipps,KathrynMaupin
• 5. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives

Introduction to 4-Nitro-2-(3-trifluoromethylphenyl)benzoic acid (CAS No. 1261742-18-0)

4-Nitro-2-(3-trifluoromethylphenyl)benzoic acid, identified by its Chemical Abstracts Service (CAS) number 1261742-18-0, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and medicinal chemistry. This compound belongs to the class of nitroaromatic benzoic acids, characterized by the presence of a nitro group and a trifluoromethyl substituent on a phenyl ring, which are key structural features influencing its chemical properties and potential biological activities.

The molecular structure of 4-Nitro-2-(3-trifluoromethylphenyl)benzoic acid consists of a benzoic acid core, which is a well-known scaffold in drug discovery, modified with a nitro group at the 4-position and a 3-trifluoromethylphenyl group at the 2-position. The nitro group introduces electrophilicity and reactivity, making the compound a valuable intermediate in synthetic chemistry. Meanwhile, the trifluoromethyl group enhances lipophilicity and metabolic stability, which are critical factors in pharmaceutical design.

Recent advancements in medicinal chemistry have highlighted the importance of nitroaromatic compounds in developing novel therapeutic agents. 4-Nitro-2-(3-trifluoromethylphenyl)benzoic acid has been explored for its potential applications in various pharmacological contexts. For instance, studies have demonstrated its utility as a precursor in synthesizing derivatives with anti-inflammatory, anticancer, and antimicrobial properties. The electron-withdrawing nature of the nitro group and the electron-donating effect of the trifluoromethyl group create a balance that influences both reactivity and binding affinity to biological targets.

In academic research, 4-Nitro-2-(3-trifluoromethylphenyl)benzoic acid has been utilized to develop novel inhibitors targeting enzymes involved in metabolic pathways relevant to diseases such as diabetes and obesity. The trifluoromethyl group's ability to modulate enzyme activity has been particularly noted in studies focusing on lipase and amylase inhibition. These findings suggest that modifications of this compound could lead to the development of next-generation therapeutic agents with improved efficacy and selectivity.

The synthesis of 4-Nitro-2-(3-trifluoromethylphenyl)benzoic acid involves multi-step organic reactions, typically starting from commercially available aromatic precursors. The introduction of the nitro group is commonly achieved through nitration reactions, while the attachment of the 3-trifluoromethylphenyl moiety often requires cross-coupling reactions such as Suzuki or Buchwald-Hartwig couplings. These synthetic strategies highlight the compound's versatility as a building block in medicinal chemistry.

From a computational chemistry perspective, 4-Nitro-2-(3-trifluoromethylphenyl)benzoic acid has been subjected to molecular modeling studies to understand its interactions with biological targets. The presence of both polar (nitro group) and non-polar (trifluoromethyl group) regions allows for diverse binding modes, which is advantageous for designing drugs with high affinity and low toxicity. Such studies have provided insights into optimizing the compound's structure for better pharmacokinetic properties.

The pharmaceutical industry has shown interest in exploring derivatives of 4-Nitro-2-(3-trifluoromethylphenyl)benzoic acid due to its promising biological profile. Researchers have synthesized analogs with varying substituents to evaluate their effects on pharmacological activity. Preliminary results indicate that modifications at different positions can significantly alter the compound's potency and selectivity, making it a valuable scaffold for drug development.

Environmental considerations also play a role in the study of 4-Nitro-2-(3-trifluoromethylphenyl)benzoic acid. While its applications are primarily focused on therapeutic uses, understanding its environmental impact is crucial for sustainable chemical synthesis. Efforts have been made to develop greener synthetic routes that minimize waste and reduce hazardous byproducts, aligning with global initiatives toward green chemistry principles.

In conclusion, 4-Nitro-2-(3-trifluoromethylphenyl)benzoic acid (CAS No. 1261742-18-0) represents an intriguing compound with significant potential in pharmaceutical research. Its unique structural features make it a versatile intermediate for synthesizing bioactive molecules targeting various diseases. As research continues to uncover new applications and optimize synthetic methodologies, this compound is poised to contribute substantially to advancements in drug discovery and development.

• 1261482-28-3(4-Nitro-2-(4-trifluoromethylphenyl)benzoic acid)
• 1261926-01-5(3-(3-Nitrophenyl)-5-trifluoromethylbenzoic acid)
• 320-37-6(4-Nitro-2-(trifluoromethyl)benzoic acid)
• 328-80-3(3-Nitro-5-(trifluoromethyl)benzoic acid)
• 400727-50-6([1,1'-BIPHENYL]-2-CARBOXYLIC ACID, 2'-NITRO-4'-(TRIFLUOROMETHYL)-)
• 1261566-18-0(4-Nitro-2-(2-trifluoromethylphenyl)benzoic acid)
• 1261858-56-3(5-Nitro-3-(4-trifluoromethylphenyl)benzoic acid)
• 1261807-11-7(5-Nitro-3-(3-trifluoromethylphenyl)benzoic acid)
• 1261888-16-7(5-Nitro-2'-(trifluoromethyl)biphenyl-3-carboxylic acid)
• 847547-06-2(5-Nitro-2-(trifluoromethyl)benzoic acid)